Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy

Clinical trial NCT02791230 · COMPLETED

Trial details

NCT number: NCT02791230
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Transthyretin (TTR) Amyloid Cardiomyopathy

Start date: 2016-06-13
Primary completion: 2023-10-26
Enrollment: 1733

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.